Beneficial therapeutic effects of Nigella sativa and/or Zingiber officinale in HCV patients in Egypt.
Ontology highlight
ABSTRACT: Hepatitis C is a major global health burden and Egypt has the highest prevalence of hepatitis C virus (HCV) worldwide. The current study was designed to evaluate the beneficial therapeutic effects of ethanolic extracts of Nigella sativa, Zingiber officinale and their mixture in Egyptian HCV patients. Sixty volunteer patients with proven HCV and fifteen age matched healthy subjects were included in this study. Exclusion criteria included patients on interferon alpha (IFN-α) therapy, infection with hepatitis B virus, drug-induced liver diseases, advanced cirrhosis, hepatocellular carcinoma (HCC) or other malignancies, blood picture abnormalities and major severe illness. Liver function enzymes, albumin, total bilirubin, prothrombin time and concentration, international normalized ratio, alph
SUBMITTER: Abdel-Moneim A
PROVIDER: S-EPMC4904745 | biostudies-literature | 2013
REPOSITORIES: biostudies-literature
ACCESS DATA